The following important updates have been made to BMJ Best Practice topics. NICE recommends teplizumab to delay progression to stage 3 type 1 diabetes Topic: Type 1 diabetes , Section: Management: emerging The National Institute for Health and Care Excellence (NICE) in the UK now recommends teplizumab as an option for delaying the onset of stage 3 type 1 diabetes in adults and children aged 8 years and over with stage 2 type 1 diabetes. Previously, there were no treatments available to delay progression to stage 3 disease, and management was limited to monitoring, education, and psychosocial support. European guidance lowers the bar for starting antiviral therapy in chronic HBV Topic: Hepatitis B , Section: Management: approach The European Association for the Study of the Liver (EASL) has published its updated clinical practice guideline on the management of hepatitis B virus (HBV) infection. Recommendations for when to start antiviral therapy have been updated to make sure patie...
Information Skills for Health
Develop your information skills to support evidence-based practice, CPD, revalidation & patient care